Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy ; day:2 ; month:5 ; year:2020 ; pages:1-10
Journal of neurology ; (2.5.2020), 1-10
- Urheber
-
Osmanovic, Alma
Ranxha, Gresa
Kumpe, Mareike
Müschen, Lars
Binz, Camilla
Wiehler, Flavia
Paracka, Lejla
Körner, Sonja
Kollewe, Katja
Petri, Susanne
Schreiber-Katz, Olivia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-020-09847-8
- URN
-
urn:nbn:de:101:1-2020071123521758856191
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Osmanovic, Alma
- Ranxha, Gresa
- Kumpe, Mareike
- Müschen, Lars
- Binz, Camilla
- Wiehler, Flavia
- Paracka, Lejla
- Körner, Sonja
- Kollewe, Katja
- Petri, Susanne
- Schreiber-Katz, Olivia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis